Revision as of 23:45, 22 January 2023 editEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers173,284 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper← Previous edit | Revision as of 20:47, 24 July 2023 edit undoJWBE (talk | contribs)Extended confirmed users10,127 edits removed Category:Para-Methoxyphenylpiperazines; added Category:Piperazines using HotCatNext edit → | ||
Line 71: | Line 71: | ||
] | ] | ||
] | ] | ||
] | ] | ||
] | ] | ||
] | ] |
Revision as of 20:47, 24 July 2023
Chemical compoundThis article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Pramiconazole" – news · newspapers · books · scholar · JSTOR (January 2021) (Learn how and when to remove this message) |
Clinical data | |
---|---|
Routes of administration | By mouth |
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C35H39F2N7O4 |
Molar mass | 659.725 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Pramiconazole is a triazole antifungal which was under development by Barrier Therapeutics for the treatment of acute skin and mucosal fungal infections but was never marketed.
References
- "Pramiconazole - AdisInsight".
- Geria AN, Scheinfeld NS (September 2008). "Pramiconazole, a triazole compound for the treatment of fungal infections". IDrugs: The Investigational Drugs Journal. 11 (9): 661–70. PMID 18763217.
This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it. |